Retension Pharmaceuticals, Inc. (RTSN)
CIK 2002988 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Retension Pharmaceuticals, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Nov 4, 2026 | 3 | 0001213900-26-115961 |
| Nov 4, 2026 | 4 | 0001213900-26-115968 |
| Oct 23, 2026 | 8-K | 0001213900-26-111794 |
| Oct 22, 2026 | 4 | 0001213900-26-111795 |
| Oct 16, 2026 | SCHEDULE 13G | 0000820434-26-000008 |
| Oct 16, 2026 | SCHEDULE 13G | 0001213900-26-110378 |
| Oct 16, 2026 | 3 | 0001213900-26-110379 |
| Oct 15, 2026 | SCHEDULE 13G | 0000935836-26-000533 |
| Oct 14, 2026 | SCHEDULE 13D | 0001213900-26-109425 |
| Oct 13, 2026 | 4 | 0001213900-26-109157 |
| Oct 13, 2026 | S-8 | 0001213900-26-109109 |
| Oct 13, 2026 | 8-K | 0001213900-26-109024 |
| Oct 13, 2026 | 4 | 0001213900-26-109155 |
| Oct 13, 2026 | 3 | 0001213900-26-109153 |
| Oct 13, 2026 | 4 | 0001213900-26-109154 |
| Oct 13, 2026 | 4 | 0001213900-26-109158 |
| Oct 13, 2026 | 4 | 0001213900-26-109156 |
| Oct 13, 2026 | 4 | 0001213900-26-109159 |
| Oct 13, 2026 | 4 | 0001213900-26-109160 |
| Oct 9, 2026 | 424B4 | 0001213900-26-108587 |
| Oct 8, 2026 | 3 | 0001213900-26-108139 |
| Oct 8, 2026 | 4 | 0001213900-26-108190 |
| Oct 8, 2026 | 4 | 0001213900-26-108189 |
| Oct 8, 2026 | 4 | 0001213900-26-108188 |
| Oct 8, 2026 | 3 | 0001213900-26-108140 |